TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. , No. 22-2124 (Fed. Cir. 2023)

Annotate this Case

Download PDF

Case: 22-2124 Document: 52 Page: 1 Filed: 10/11/2023 NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs-Appellees v. ZYDUS PHARMACEUTICALS (USA) INC., CADILA HEALTHCARE LTD., Defendants-Appellants ______________________ 2022-2124 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 3:18-cv-11792-FLW-TJB, Judge Freda L. Wolfson. ______________________ JUDGMENT ______________________ ERIC J. LOBENFELD, Cherry Hill, NJ, argued for plaintiffs-appellees. Also represented by BENJAMIN HOLT, RYAN STEPHENSON, Hogan Lovells US LLP, Washington, DC. STEVEN J. MOORE, Withers Bergman LLP, Greenwich, Case: 22-2124 Document: 52 Page: 2 Filed: 10/11/2023 CT, argued for defendants-appellants. Also represented by JAMES EDWARD NEALON, Nealon Law LLC, Stamford, CT. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (MOORE, Chief Judge, STOLL and CUNNINGHAM, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT October 11, 2023 Date

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.